The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PSMA-based PET imaging in newly diagnosed, high-risk localized prostate cancer, a National Cancer Institute (NCI) Cancer Moonshot trial.
 
Nikhil Pramod
No Relationships to Disclose
 
Baris Turkbey
No Relationships to Disclose
 
Peter Choyke
No Relationships to Disclose
 
Liza Lindenberg
No Relationships to Disclose
 
Esther Mena
No Relationships to Disclose
 
Ravi Madan
Research Funding - Bayer
 
Michele Reed
No Relationships to Disclose
 
Philip Eclarinal
No Relationships to Disclose
 
Maria Merino
No Relationships to Disclose
 
Adam Sowalsky
No Relationships to Disclose
 
Krishnan Patel
No Relationships to Disclose
 
Deborah Citrin
Employment - US Oncology (I)
 
James Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); ImmunityBio (Inst); Incyte (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Marengo Therapeutics (Inst); Merck (Inst); NextCure (Inst); PDS Biotechnology (Inst); Pfizer (Inst); Precigen (Inst); Syndax (Inst); Syntrix Biosystems (Inst)
Patents, Royalties, Other Intellectual Property - COMBINATION PDL1 AND TGF-BETA BLOCKADE IN PATIENTS WITH HPV+ MALIGNANCIES Publication number: 20200062849 Abstract: The invention provides a method of inhibiting a malignancy associated with human papilloma virus (HPV) comprising administering to a subje
 
William Figg
Research Funding - Astellas Pharma (Inst); Biocompatibles (Inst); Celgene (Inst); Nerviano Medical Sciences (Inst); NovaRX (Inst); Pfizer (Inst); Propella Therapeutics (Inst); TRACON Pharma (Inst)
 
William Dahut
Leadership - Dexcom (I)
Stock and Other Ownership Interests - Dexcom (I)
 
Peter Pinto
No Relationships to Disclose
 
Fatima Karzai
No Relationships to Disclose